Premier Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Premier Asset Management LLC

$0
Q1 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $732,713 - $795,512	-1,038 Reduced 33.91%	2,023 $1.46 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $505,093 - $637,401	-880 Reduced 22.33%	3,061 $2.11 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $3.42 Million - $4.61 Million	-6,235 Reduced 61.27%	3,941 $2.29 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $3.25 Million - $3.82 Million	-5,463 Reduced 34.93%	10,176 $7.11 Million
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $2.95 Million - $3.64 Million	-5,425 Reduced 25.75%	15,639 $9.88 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $679,651 - $806,256	1,184 Added 5.96%	21,064 $12.7 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $9.4 Million - $11.1 Million	19,880 New	19,880 $11.1 Million
Q2 2020 Jul 31, 2020	SELL	$493.32 - $643.92 $4.73 Million - $6.18 Million	-9,594 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $3.23 Million - $4.74 Million	9,594 New	9,594 $4.69 Million
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $10.2 Million - $14.1 Million	-33,911 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $150,320 - $177,586	404 Added 1.21%	33,911 $13.9 Million
Q4 2018 Feb 15, 2019	BUY	$335.82 - $403.04 $89,663 - $107,611	267 Added 0.8%	33,507 $12.5 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $221,218 - $257,361	-630 Reduced 1.86%	33,240 $13.4 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.14 Million - $1.38 Million	4,005 Added 13.41%	33,870 $11.7 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $319,294 - $398,111	-1,011 Reduced 3.27%	29,865 $10.3 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $602,857 - $789,985	-1,681 Reduced 5.16%	30,876 $11.6 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $14 Million - $16.4 Million	32,557	32,557 $14.6 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Account